Connection

William Vandergrift to Receptors, Fibroblast Growth Factor

This is a "connection" page, showing publications William Vandergrift has written about Receptors, Fibroblast Growth Factor.
  1. In?Vitro Effect of Dovitinib (TKI258), a Multi-Target Angiokinase Inhibitor on Aggressive Meningioma Cells. Cancer Invest. 2020 Jul; 38(6):349-355.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.